Actinomyces naeslundii DSM 43013 is an anaerobe, Gram-positive, rod-shaped human pathogen that was isolated from human sinus.
Gram-positive rod-shaped anaerobe human pathogen genome sequence 16S sequence Bacteria SI-ID 35497
| @ref 20215 |
|
Last LPSN update
2026-05-29 08:24:57 |
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Actinomycetales |
| Family Actinomycetaceae |
| Genus Actinomyces |
| Species Actinomyces naeslundii |
| Full scientific name Actinomyces naeslundii corrig. Thompson and Lovestedt 1951 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 32933 | MEDIUM 6 - Columbia agar with 10 % horse blood | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml) | |||
| 10673 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 10673 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 121221 | CIP Medium 6 | Medium recipe at CIP |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | + | builds acid from | from API 50CH acid |
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 121221 | 16947 ChEBI | citrate | - | carbon source | |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68377 | 15824 ChEBI | D-fructose | + | builds acid from | from API NH |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68379 | 17634 ChEBI | D-glucose | + | fermentation | from API Coryne |
| 68377 | 17634 ChEBI | D-glucose | + | builds acid from | from API NH |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68379 | 16899 ChEBI | D-mannitol | - | fermentation | from API Coryne |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68380 | 16024 ChEBI | D-mannose | + | fermentation | from API rID32A |
| 68371 | 16988 ChEBI | D-ribose | - | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68379 | 65327 ChEBI | D-xylose | - | fermentation | from API Coryne |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 68379 | 4853 ChEBI | esculin | + | hydrolysis | from API Coryne |
| 121221 | 4853 ChEBI | esculin | + | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | + | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68379 | 5291 ChEBI | gelatin | - | hydrolysis | from API Coryne |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | + | builds acid from | from API 50CH acid |
| 68371 | 17754 ChEBI | glycerol | + | builds acid from | from API 50CH acid |
| 68379 | 28087 ChEBI | glycogen | - | fermentation | from API Coryne |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 121221 | 606565 ChEBI | hippurate | - | hydrolysis | |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | + | builds acid from | from API 50CH acid |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17716 ChEBI | lactose | + | builds acid from | from API 50CH acid |
| 68379 | 17306 ChEBI | maltose | + | fermentation | from API Coryne |
| 68377 | 17306 ChEBI | maltose | + | builds acid from | from API NH |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | + | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | + | builds acid from | from API 50CH acid |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 68379 | 17632 ChEBI | nitrate | + | reduction | from API Coryne |
| 121221 | 17632 ChEBI | nitrate | + | reduction | |
| 121221 | 17632 ChEBI | nitrate | + | respiration | |
| 68380 | 17632 ChEBI | nitrate | + | reduction | from API rID32A |
| 121221 | 16301 ChEBI | nitrite | - | reduction | |
| 68377 | 18257 ChEBI | ornithine | - | degradation | from API NH |
| 68371 | 0 ChEBI | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid |
| 68371 | 0 ChEBI | Potassium 5-ketogluconate | + | builds acid from | from API 50CH acid |
| 68371 | 16634 ChEBI | raffinose | + | builds acid from | from API 50CH acid |
| 68380 | 16634 ChEBI | raffinose | + | fermentation | from API rID32A |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | + | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68379 | 17992 ChEBI | sucrose | + | fermentation | from API Coryne |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68377 | 17992 ChEBI | sucrose | + | builds acid from | from API NH |
| 68371 | 27082 ChEBI | trehalose | + | builds acid from | from API 50CH acid |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68377 | 27897 ChEBI | tryptophan | - | energy source | from API NH |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| 68377 | 16199 ChEBI | urea | + | hydrolysis | from API NH |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 121221 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | - | 3.1.3.2 | from API zym |
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 121221 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68380 | alkaline phosphatase | - | 3.1.3.1 | from API rID32A |
| 68377 | alkaline phosphatase | - | 3.1.3.1 | from API NH |
| 68379 | alkaline phosphatase | - | 3.1.3.1 | from API Coryne |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68382 | alpha-galactosidase | + | 3.2.1.22 | from API zym |
| 68380 | alpha-galactosidase | + | 3.2.1.22 | from API rID32A |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68380 | alpha-glucosidase | + | 3.2.1.20 | from API rID32A |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 121221 | amylase | - | ||
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 121221 | beta-galactosidase | + | 3.2.1.23 | |
| 68377 | beta-galactosidase | + | 3.2.1.23 | from API NH |
| 68379 | beta-galactosidase | + | 3.2.1.23 | from API Coryne |
| 68380 | beta-galactosidase | + | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68382 | beta-glucosidase | + | 3.2.1.21 | from API zym |
| 68380 | beta-glucosidase | + | 3.2.1.21 | from API rID32A |
| 68379 | beta-glucosidase | + | 3.2.1.21 | from API Coryne |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 68379 | beta-glucuronidase | - | 3.2.1.31 | from API Coryne |
| 68377 | beta-lactamase | - | 3.5.2.6 | from API NH |
| 121221 | caseinase | + | 3.4.21.50 | |
| 121221 | catalase | + | 1.11.1.6 | |
| 68379 | catalase | - | 1.11.1.6 | from API Coryne |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 121221 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | - | from API zym | |
| 121221 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 68377 | gamma-glutamyltransferase | - | 2.3.2.2 | from API NH |
| 121221 | gelatinase | - | ||
| 68379 | gelatinase | - | from API Coryne | |
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | L-arginine arylamidase | - | from API rID32A | |
| 121221 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68380 | leucine arylamidase | + | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 121221 | lipase | - | ||
| 68377 | lipase | - | from API NH | |
| 68382 | lipase (C 14) | - | from API zym | |
| 121221 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68380 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API rID32A |
| 68379 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API Coryne |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 121221 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68377 | ornithine decarboxylase | - | 4.1.1.17 | from API NH |
| 121221 | oxidase | - | ||
| 121221 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 68380 | phenylalanine arylamidase | + | from API rID32A | |
| 68377 | proline-arylamidase | - | 3.4.11.5 | from API NH |
| 68380 | proline-arylamidase | + | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68379 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API Coryne |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 121221 | tryptophan deaminase | - | ||
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 68377 | tryptophan deaminase | - | 4.1.99.1 | from API NH |
| 121221 | tween esterase | +/- | ||
| 68380 | tyrosine arylamidase | + | from API rID32A | |
| 121221 | urease | + | 3.5.1.5 | |
| 68377 | urease | + | 3.5.1.5 | from API NH |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68382 | valine arylamidase | - | from API zym |
Metadata FA analysis  | |||||||||||||||||||||||||
| @ref | 65608 | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| @ref | Reduction of nitrateNIT | PYZ | PYRA | PAL | beta GUR | beta GAL | alpha GLU | beta NAG | ESC | URE | GEL | Control fermentationControl | GLU | RIB | XYL | MAN | MAL | LAC | SAC | GLYG | CAT | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65608 | + | + | - | - | - | + | + | - | + | + | - | - | not determinedn.d. | + | - | - | + | + | + | - | - | |
| 10673 | + | - | - | - | - | + | - | - | + | - | - | - | + | - | - | - | + | - | + | - | not determinedn.d. | |
| 10673 | + | + | - | - | - | + | +/- | - | + | - | - | - | + | - | - | - | + | + | + | - | - |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121221 | not determinedn.d. | + | - | - | - | - | - | - | - | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | + | + | + | - | + | + | + | + | + | - | - | + | - | - | - | - | - | - | - | - | + | - | - | + | - | + |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10673 | - | - | + | + | - | + | + | - | - | - | + | + | - | - | + | - | - | - | + | - | + | + | - | + | - | +/- | - | - | - | |
| 10673 | - | - | + | + | - | + | + | - | - | - | + | + | - | - | + | - | - | - | + | - | + | + | - | + | - | - | - | - | - | |
| 65608 | - | - | + | + | - | + | + | - | - | - | + | + | - | - | + | - | - | - | + | - | + | + | - | + | - | - | - | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body-Site | #Oral cavity and airways | - | |
| #Host Body-Site | #Other | #Head |
Global distribution of 16S sequence NR_113326 (>99% sequence identity) for Actinomyces naeslundii subclade from Microbeatlas 
 Aquatic Samples |
595 |
 Soil Samples |
345 |
 Animal Samples |
22069 |
 Plant Samples |
125 |
| Total Samples | 23134 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 124043 | ASM3129665v1 assembly for Actinomyces naeslundii NCTC 10301 | contig | GCA_031296655   | 1655.282  | 1655 | 69.64 | | |
| 67770 | ASM195658v1 assembly for Actinomyces naeslundii NCTC 10301 | scaffold | GCA_001956585 | 1655.49 | 1655 | 66.48 | ||
| 124043 | ASM3129659v1 assembly for Actinomyces naeslundii ATCC 12104 | contig | GCA_031296595 | 1655.281 | 1655 | 64.7 | | |
| 124043 | ASM3129671v1 assembly for Actinomyces naeslundii NCTC 10301 | contig | GCA_031296715 | 1655.283 | 1655 | 56.28 | | |
| 66792 | AneasH279v1.0 assembly for Actinomyces naeslundii str. Howell 279 | contig | GCA_000285995 | 1115803.3 | 2531839542  | 1115803 | 24.35 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Actinomyces naeslundii 16S ribosomal RNA gene, partial sequence | AF058052 | 283 | | 1655 | |
| 20218 | Actinomyces naeslundii partial 16S rRNA | X53226 | 1376 | | 1655 | |
| 10673 | Actinomyces naeslundii strain CDC W826 16S ribosomal RNA, partial sequence | NR_037033 | 1450 | | 1655 | |
| 10673 | Actinomyces naeslundii strain JCM 8349 16S ribosomal RNA, partial sequence | NR_113326 | 1522 | | 1655 | |
| 67770 | Actinomyces naeslundii gene for 16S ribosomal RNA, partial cds, strain: JCM 8349 | AB618790 | 1522 | | 1655 | |
| 67770 | A.naeslundii 16S ribosomal RNA | M33911 | 1378 | | 1655 | |
| 67770 | A.naeslundii 16S rRNA gene | X81062 | 1450 | | 1655 | |
| 124043 | Actinomyces naeslundii strain NCTC 10301 16S ribosomal RNA gene, partial sequence. | OR133754 | 1472 | | 1655 | |
| 124043 | Actinomyces naeslundii strain ATCC 12104 16S ribosomal RNA gene, partial sequence. | OR133756 | 1567 | | 1655 | |
| 10673 | GC-content (mol%)66 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Influence of species composition and cultivation condition on peri-implant biofilm dysbiosis in vitro. | Heine N, Bittroff K, Szafranski SP, Duitscher M, Behrens W, Vollmer C, Mikolai C, Kommerein N, Debener N, Frings K, Heisterkamp A, Scheper T, Torres-Mapa ML, Bahnemann J, Stiesch M, Doll-Nikutta K. | Front Oral Health | 10.3389/froh.2025.1649419 | 2025 | | |
| Antibacterial Effect of Ozone on Cariogenic Bacteria and Its Potential Prejudicial Effect on Dentin Bond Strength-An In Vitro Study. | Santos M, Leandro F, Barroso H, Delgado AHS, Proenca L, Polido M, Vasconcelos E Cruz J. | Pharmaceutics | 10.3390/pharmaceutics16050614 | 2024 | | |
| Fluorescence Spectroscopy Shows Porphyrins Produced by Cultured Oral Bacteria Differ Depending on Composition of Growth Media. | Lennon AM, Brune L, Techert S, Buchalla W. | Caries Res | 10.1159/000528731 | 2023 | | |
| Impact of antibacterial therapeutic agents on biofilm-tissue interactions in a 3D implant-tissue-oral-bacterial-biofilm model | Mikolai C, Woll K, Rahim M, Winkel A, Falk C, Stiesch M. | Sci Rep | 2025 | | ||
| Optically accessible, 3D-printed flow chamber with integrated sensors for the monitoring of oral multispecies biofilm growth in vitro. | Debener N, Heine N, Legutko B, Denkena B, Prasanthan V, Frings K, Torres-Mapa ML, Heisterkamp A, Stiesch M, Doll-Nikutta K, Bahnemann J. | Front Bioeng Biotechnol | 10.3389/fbioe.2024.1483200 | 2024 | | |
| Colorimetric detection of oral bacteria using functionalized gold nanoparticles as a plasmonic biosensor array. | Wenck C, Leopoldt D, Habib M, Hegermann J, Stiesch M, Doll-Nikutta K, Heisterkamp A, Torres-Mapa ML. | Nanoscale Adv | 10.1039/d3na00477e | 2024 | | |
| Silver Nanoparticles Produced by Laser Ablation and Re-Irradiation Are Effective Preventing Peri-Implantitis Multispecies Biofilm Formation. | Perez-Tanoira R, Fernandez-Arias M, Potel C, Carballo-Fernandez R, Perez-Castro S, Boutinguiza M, Gorgolas M, Lusquinos F, Pou J. | Int J Mol Sci | 10.3390/ijms231912027 | 2022 | | |
| Adhesion Forces of Oral Bacteria to Titanium and the Correlation with Biophysical Cellular Characteristics. | Doll-Nikutta K, Winkel A, Yang I, Grote AJ, Meier N, Habib M, Menzel H, Behrens P, Stiesch M. | Bioengineering (Basel) | 10.3390/bioengineering9100567 | 2022 | | |
| Biocompatible liquid-infused titanium minimizes oral biofilm adhesion in flow chamber and 3D implant-tissue-biofilm in vitro models | Doll-Nikutta K, Mikolai C, Heine N, Kurselis K, Fadeeva E, Debener N, Legutko B, Kreuzkamp C, Prasanthan V, Bahnemann J, Chichkov B, Stiesch M. | Bioact Mater | 2025 | | ||
| Effect of Low-Level Laser Irradiation (810 nm) on the Proliferation and Differentiation of Osteoblast-Like Cells Cultured on SLA Titanium Discs Exposed to a Peri-implantitis Environment. | Zampa EP, Kyriakidou K, Papaparaskevas J, Pepelassi E, Karoussis IK. | J Lasers Med Sci | 10.34172/jlms.2023.57 | 2023 | | |
| Dual Antibacterial and Soft-Tissue-Integrative Effect of Combined Strontium Acetate and Silver Nitrate on Peri-Implant Environment: Insights from Multispecies Biofilms and a 3D Coculture Model. | Kheirmand-Parizi M, Doll-Nikutta K, Mikolai C, Wirth D, Menzel H, Stiesch M. | ACS Appl Mater Interfaces | 10.1021/acsami.5c01093 | 2025 | | |
| Probiotic Effects on Multispecies Biofilm Composition, Architecture, and Caries Activity In Vitro. | Chen Z, Schlafer S, Gostemeyer G, Schwendicke F. | Microorganisms | 10.3390/microorganisms8091272 | 2020 | | |
| Metabolism | Effect of reduced nutritional supply on the metabolic activity and survival of cariogenic bacteria in vitro. | Ganas P, Schwendicke F. | J Oral Microbiol | 10.1080/20002297.2019.1605788 | 2019 | |
| Root Caries Preventive Effect of Varnishes Containing Fluoride or Fluoride + Chlorhexidine/Cetylpyridinium Chloride In Vitro. | Gostemeyer G, Woike H, Paris S, Schwendicke F, Schlafer S. | Microorganisms | 10.3390/microorganisms9040737 | 2021 | | |
| Plant-based oral care product exhibits antibacterial effects on different stages of oral multispecies biofilm development in vitro. | Kommerein N, Weigel AJ, Stiesch M, Doll K. | BMC Oral Health | 10.1186/s12903-021-01504-4 | 2021 | | |
| Pathogenicity | Antimicrobial efficacy of alternative compounds for use in oral care toward biofilms from caries-associated bacteria in vitro. | Cieplik F, Kara E, Muehler D, Enax J, Hiller KA, Maisch T, Buchalla W. | Microbiologyopen | 10.1002/mbo3.695 | 2019 | |
| Development and characterization of an oral multispecies biofilm implant flow chamber model. | Kommerein N, Doll K, Stumpp NS, Stiesch M. | PLoS One | 10.1371/journal.pone.0196967 | 2018 | | |
| Insights Into Mechanisms of Antimicrobial Photodynamic Action Toward Biofilms Using Phenalen-1-One Derivatives as Photosensitizers. | Muehler D, Rupp CM, Keceli S, Brochhausen C, Siegmund H, Maisch T, Hiller KA, Buchalla W, Cieplik F. | Front Microbiol | 10.3389/fmicb.2020.589364 | 2020 | | |
| Phenalen-1-one-Mediated Antimicrobial Photodynamic Therapy: Antimicrobial Efficacy in a Periodontal Biofilm Model and Flow Cytometric Evaluation of Cytoplasmic Membrane Damage. | Cieplik F, Steinwachs VS, Muehler D, Hiller KA, Thurnheer T, Belibasakis GN, Buchalla W, Maisch T. | Front Microbiol | 10.3389/fmicb.2018.00688 | 2018 | | |
| Limited antimicrobial efficacy of oral care antiseptics in microcosm biofilms and phenotypic adaptation of bacteria upon repeated exposure. | Schwarz SR, Hirsch S, Hiergeist A, Kirschneck C, Muehler D, Hiller KA, Maisch T, Al-Ahmad A, Gessner A, Buchalla W, Cieplik F. | Clin Oral Investig | 10.1007/s00784-020-03613-w | 2021 | | |
| Enzymology | Efficiency of chemical versus mechanical disruption methods of DNA extraction for the identification of oral Gram-positive and Gram-negative bacteria. | Li X, Bosch-Tijhof CJ, Wei X, de Soet JJ, Crielaard W, Loveren CV, Deng DM. | J Int Med Res | 10.1177/0300060520925594 | 2020 | |
| Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. | Elshikh M, Ahmed S, Funston S, Dunlop P, McGaw M, Marchant R, Banat IM. | Biotechnol Lett | 10.1007/s10529-016-2079-2 | 2016 | | |
| Metabolism | An oral multispecies biofilm model for high content screening applications. | Kommerein N, Stumpp SN, Musken M, Ehlert N, Winkel A, Haussler S, Behrens P, Buettner FF, Stiesch M. | PLoS One | 10.1371/journal.pone.0173973 | 2017 | |
| Compilation of small ribosomal subunit RNA structures. | Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R. | Nucleic Acids Res | 10.1093/nar/21.13.3025 | 1993 | | |
| Metabolism | The Effect of Environmental Factors on the Nitrate and Nitrite Metabolism of Oral Actinomyces and Schaalia Species. | Otake T, Washio J, Ezoe K, Sato S, Abiko Y, Igarashi K, Takahashi N. | Mol Oral Microbiol | 10.1111/omi.12492 | 2025 | |
| Nanotopography and oral bacterial adhesion on titanium surfaces: in vitro and in vivo studies. | Schwartz-Filho HO, Martins TR, Sano PR, Araujo MT, Chan DCH, Saldanha NR, Silva KP, Graziano TS, Brandt WC, Torres CVR, Cogo-Muller K. | Braz Oral Res | 10.1590/1807-3107bor-2024.vol38.0021 | 2024 | | |
| Microbial Coaggregation in the Oral Cavity: Molecular Interactions and Current Insights. | Oogai Y, Tanaka Y, Nakata M. | Int J Mol Sci | 10.3390/ijms262110552 | 2025 | | |
| The Impact of Silver Nanoparticles' Size on Biofilm Eradication. | Fakeeha G, AlHarbi S, Auda S, Balto H. | Int Dent J | 10.1016/j.identj.2024.08.007 | 2025 | | |
| In Vitro Inhibitory Effect of Silver Diamine Fluoride Combined with Potassium Iodide against Mixed-Species Biofilm Formation on Human Root Dentin. | Manuschai J, Sotozono M, Takenaka S, Kornsombut N, Takahashi R, Saito R, Nagata R, Ida T, Noiri Y. | Antibiotics (Basel) | 10.3390/antibiotics13080743 | 2024 | | |
| Antibacterial Properties of the Antimicrobial Peptide Gallic Acid-Polyphemusin I (GAPI). | Zhang OL, Niu JY, Yin IX, Yu OY, Mei ML, Chu CH. | Antibiotics (Basel) | 10.3390/antibiotics12091350 | 2023 | | |
| Effect of sodium hypochlorite gel on bacteria associated with periodontal disease. | Irani D, Jungbauer G, Sculean A, Eick S. | Clin Oral Investig | 10.1007/s00784-023-05446-9 | 2024 | | |
| Salivary pellicle modulates biofilm formation on titanium surfaces. | Martinez-Hernandez M, Reyes-Grajeda JP, Hannig M, Almaguer-Flores A. | Clin Oral Investig | 10.1007/s00784-023-05230-9 | 2023 | | |
| Genetics | Genomic Diversity among Actinomyces naeslundii Strains and Closely Related Species. | Mughal SR, Niazi SA, Do T, Gilbert SC, Didelot X, Radford DR, Beighton D. | Microorganisms | 10.3390/microorganisms11020254 | 2023 | |
| Antibacterial efficacy of quaternary ammonium compounds (QACs) against Enterococcus faecalis in endodontic infections: a systematic review and meta-analysis. | Bapat RA, Eusufzai SZ, Akram Z, Chaubal T, Phaik KS, Seow LL, Daood U. | BMC Oral Health | 10.1186/s12903-025-06573-3 | 2025 | | |
| Potential in vitro anti-periodontopathogenic, anti-Chikungunya activities and in vivo toxicity of Brazilian red propolis. | Silva NBS, de Souza JH, Santiago MB, da Silva Aguiar JR, Martins DOS, da Silva RA, de Andrade Santos I, Aldana-Mejia JA, Jardim ACG, Dos Santos Pedroso R, Ambrosio SR, Veneziani RCS, Bastos JK, Pires RH, Martins CHG. | Sci Rep | 10.1038/s41598-022-24776-4 | 2022 | | |
| In-Vitro Effect of Manuka Honey / Propolis Toothpastes on Bacteria and Biofilm Associated with Caries and Gingivitis. | Jungbauer G, Lechner R, Stahli A, Sculean A, Eick S. | Oral Health Prev Dent | 10.3290/j.ohpd.c_1910 | 2025 | | |
| Salivary levels of five microorganisms of root caries in nursing home elderly: a preliminary investigation. | Chen L, Qin Y, Lin Y, Du M, Li Y, Fan M. | BMC Oral Health | 10.1186/s12903-023-02953-9 | 2023 | | |
| Comparison of In Vitro Biofilm Formation on Titanium and Zirconia Implants. | Chiou LL, Panariello BHD, Hamada Y, Gregory RL, Blanchard S, Duarte S. | Biomed Res Int | 10.1155/2023/8728499 | 2023 | | |
| Electrospun Azithromycin-Laden Gelatin Methacryloyl Fibers for Endodontic Infection Control. | Ayoub AA, Mahmoud AH, Ribeiro JS, Daghrery A, Xu J, Fenno JC, Schwendeman A, Sasaki H, Dal-Fabbro R, Bottino MC. | Int J Mol Sci | 10.3390/ijms232213761 | 2022 | | |
| Bovine Milk and Yogurt Affect Oral Microorganisms and Biofilms In-Vitro. | Tennert C, Sarra G, Stahli A, Sculean A, Eick S. | Oral Health Prev Dent | 10.3290/j.ohpd.b3920023 | 2023 | | |
| In Vitro Activity of Propolis on Oral Microorganisms and Biofilms. | Stahli A, Schroter H, Bullitta S, Serralutzu F, Dore A, Nietzsche S, Milia E, Sculean A, Eick S. | Antibiotics (Basel) | 10.3390/antibiotics10091045 | 2021 | | |
| Anti-oral Microbial Flavanes from Broussonetia papyrifera Under the Guidance of Bioassay. | Geng CA, Yan MH, Zhang XM, Chen JJ. | Nat Prod Bioprospect | 10.1007/s13659-019-0197-y | 2019 | | |
| One-Pot Preparation of Cetylpyridinium Chloride-Containing Nanoparticles for Biofilm Eradication. | Brezhnev A, Tang FK, Kwan CS, Basabrain MS, Tsoi JKH, Matinlinna JP, Neelakantan P, Leung KC. | ACS Appl Bio Mater | 10.1021/acsabm.2c01080 | 2023 | | |
| Streptococcus mutans and Actinomyces naeslundii Interaction in Dual-Species Biofilm. | de Oliveira RVD, Bonafe FSS, Spolidorio DMP, Koga-Ito CY, Farias AL, Kirker KR, James GA, Brighenti FL. | Microorganisms | 10.3390/microorganisms8020194 | 2020 | | |
| Effect of Cavity Cleanser With Long-Term Antibacterial and Anti-Proteolytic Activities on Resin-Dentin Bond Stability. | Gou Y, Jin W, He Y, Luo Y, Si R, He Y, Wang Z, Li J, Liu B. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.784153 | 2021 | | |
| Antimicrobial Activity of Methylene Blue Associated with Photodynamic Therapy: In Vitro Study in Multi-Species Oral Biofilm. | Bueno-Silva B, Parma-Garcia J, Frigo L, Suarez LJ, Macedo TT, Uyeda FH, Melo MARDC, Sacco R, Mourao CF, Feres M, Shibli JA, Figueiredo LC. | Pathogens | 10.3390/pathogens13040342 | 2024 | | |
| Anti-biofilm Activity of Oral Health-care Products Containing Chlorhexidine Digluconate and Citrox. | Jeyakumar J, Sculean A, Eick S. | Oral Health Prev Dent | 10.3290/j.ohpd.a45437 | 2020 | | |
| Pathogenicity | Antibacterial Activity of a Bioactive Tooth-Coating Material Containing Surface Pre-Reacted Glass in a Complex Multispecies Subgingival Biofilm. | Tanaka CJ, Rodrigues JA, Pingueiro JMS, Macedo TT, Feres M, Shibli JA, Bueno-Silva B. | Pharmaceutics | 10.3390/pharmaceutics15061727 | 2023 | |
| Evaluation of the Microbial Profile on the Polydioxanone Membrane and the Collagen Membrane Exposed to Multi-Species Subgingival Biofilm: An In Vitro Study. | Cintra Moreira MV, Figueiredo LC, da Cunha Melo MAR, Uyeda FH, da Silva LDA, Macedo TT, Sacco R, Mourao CF, Shibli JA, Bueno-Silva B. | Membranes (Basel) | 10.3390/membranes13120907 | 2023 | | |
| Pathogenicity | Impact of honey on dental erosion and adhesion of early bacterial colonizers. | Habluetzel A, Schmid C, Carvalho TS, Lussi A, Eick S. | Sci Rep | 10.1038/s41598-018-29188-x | 2018 | |
| Effect of flavonoids on antimicrobial activity of microorganisms present in dental plaque. | Gutierrez-Venegas G, Gomez-Mora JA, Meraz-Rodriguez MA, Flores-Sanchez MA, Ortiz-Miranda LF. | Heliyon | 10.1016/j.heliyon.2019.e03013 | 2019 | | |
| An In Vitro study to Compare Dental Laser with other Treatment Modalities on Biofilm Ablation from Implant and Tooth Surfaces. | Vaddamanu SK, Vyas R, Kavita K, Sushma R, Rani RP, Dixit A, Badiyani BK. | J Pharm Bioallied Sci | 10.4103/jpbs.jpbs_98_22 | 2022 | | |
| Injectable thermosensitive antibiotic-laden chitosan hydrogel for regenerative endodontics. | Reis-Prado AHD, Rahimnejad M, Dal-Fabbro R, Toledo PTA, Anselmi C, Oliveira PHC, Fenno JC, Cintra LTA, Benetti F, Bottino MC. | Bioact Mater | 10.1016/j.bioactmat.2024.12.026 | 2025 | | |
| Engineering of Injectable Antibiotic-laden Fibrous Microparticles Gelatin Methacryloyl Hydrogel for Endodontic Infection Ablation. | Ribeiro JS, Munchow EA, Bordini EAF, Rodrigues NS, Dubey N, Sasaki H, Fenno JC, Schwendeman S, Bottino MC. | Int J Mol Sci | 10.3390/ijms23020971 | 2022 | | |
| Gelatin methacryloyl hydrogel as an injectable scaffold with multi-therapeutic effects to promote antimicrobial disinfection and angiogenesis for regenerative endodontics. | Dubey N, Ribeiro JS, Zhang Z, Xu J, Ferreira JA, Qu L, Mei L, Fenno JC, Schwendeman A, Schwendeman SP, Nor JE, Bottino MC. | J Mater Chem B | 10.1039/d2tb02788g | 2023 | | |
| Lactobacillus acidophilus impairs the establishment of pathogens in a subgingival multispecies biofilm. | Bueno MR, Dudu-Silva G, Macedo TT, Gomes APAP, Rodrigues Oliveira Braga A, Aguiar Silva LD, Bueno-Silva B. | Front Dent Med | 10.3389/fdmed.2023.1212773 | 2023 | | |
| Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. | Enigk K, Jentsch H, Rodloff AC, Eschrich K, Stingu CS. | J Oral Microbiol | 10.1080/20002297.2020.1829405 | 2020 | | |
| The Proteome of Community Living Candida albicans Is Differentially Modulated by the Morphologic and Structural Features of the Bacterial Cohabitants. | Truong T, Pang LM, Rajan S, Wong SSW, Fung YME, Samaranayake L, Seneviratne CJ. | Microorganisms | 10.3390/microorganisms8101541 | 2020 | | |
| Succession of oral bacterial colonizers on dental implant materials: An in vitro biofilm model. | Siddiqui DA, Fidai AB, Natarajan SG, Rodrigues DC. | Dent Mater | 10.1016/j.dental.2021.12.021 | 2022 | | |
| Phylogeny | Biofilm growth and microbial contamination of dental unit waterlines at Kuwait University dental center. | Hussain Akbar J, Behbehani J, Karched M. | Front Oral Health | 10.3389/froh.2022.1071018 | 2022 | |
| Influence of oral bacteria on adhesion of Streptococcus mutans and Streptococcus sanguinis to dental materials. | Nabert-Georgi C, Rodloff AC, Jentsch H, Reissmann DR, Schaumann R, Stingu CS. | Clin Exp Dent Res | 10.1002/cre2.107 | 2018 | | |
| Pathogenicity | Starvation Survival and Biofilm Formation under Subminimum Inhibitory Concentration of QAMs. | Tiwari SK, Wang S, Huang Y, Zhou X, Xu HHK, Ren B, Peng X, Xiao Y, Li M, Cheng L. | Biomed Res Int | 10.1155/2021/8461245 | 2021 | |
| MecA in Streptococcus mutans is a multi-functional protein. | Ellepola K, Shields RC, Kajfasz JK, Zhang H, Lemos JA, Wu H, Wen ZT. | mSphere | 10.1128/msphere.00308-24 | 2024 | | |
| In vitro activity of hyaluronic acid and human serum on periodontal biofilm and periodontal ligament fibroblasts. | Zhu X, von Werdt L, Zappala G, Sculean A, Eick S, Stahli A. | Clin Oral Investig | 10.1007/s00784-023-05121-z | 2023 | | |
| Enzymology | Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis. | Kaminska M, Aliko A, Hellvard A, Bielecka E, Binder V, Marczyk A, Potempa J, Delaleu N, Kantyka T, Mydel P. | J Periodontol | 10.1002/jper.18-0179 | 2019 | |
| Microbial Adhesion and Biofilm Formation on Bioactive Surfaces of Ti-35Nb-7Zr-5Ta Alloy Created by Anodization. | Fais LMG, de Sales Leite L, Reis BAD, Ribeiro ALR, Vaz LG, Klein MI. | Microorganisms | 10.3390/microorganisms9102154 | 2021 | | |
| Low-Temperature Plasma Short Exposure to Decontaminate Peri-Implantitis-Related Multispecies Biofilms on Titanium Surfaces In Vitro. | Panariello BHD, Mody DP, Eckert GJ, Witek L, Coelho PG, Duarte S. | Biomed Res Int | 10.1155/2022/1549774 | 2022 | | |
| Pathogenicity | In-vitro effects of different hyaluronic acids on periodontal biofilm-immune cell interaction. | Zhu X, Sculean A, Eick S. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1414861 | 2024 | |
| The In-Vitro Activity of a Cold Atmospheric Plasma Device Utilizing Ambient Air against Bacteria and Biofilms Associated with Periodontal or Peri-Implant Diseases. | Jungbauer G, Favaro L, Muller S, Sculean A, Eick S. | Antibiotics (Basel) | 10.3390/antibiotics11060752 | 2022 | | |
| Propolis, Aloe Vera, Green Tea, Cranberry, Calendula, Myrrha and Salvia Properties against Periodontal Microorganisms. | Figueiredo LC, Freitas Figueiredo N, da Cruz DF, Baccelli GT, Sarachini GE, Bueno MR, Feres M, Bueno-Silva B. | Microorganisms | 10.3390/microorganisms10112172 | 2022 | | |
| Pathogenicity | Cytotoxicity and Antimicrobial Activity of Oral Rinses In Vitro. | Muller HD, Eick S, Moritz A, Lussi A, Gruber R. | Biomed Res Int | 10.1155/2017/4019723 | 2017 | |
| Corynebacterium matruchotii Demography and Adhesion Determinants in the Oral Cavity of Healthy Individuals. | Esberg A, Barone A, Eriksson L, Lif Holgerson P, Teneberg S, Johansson I. | Microorganisms | 10.3390/microorganisms8111780 | 2020 | | |
| Metabolism | Streptococcus gordonii Type I Lipoteichoic Acid Contributes to Surface Protein Biogenesis. | Lima BP, Kho K, Nairn BL, Davies JR, Svensater G, Chen R, Steffes A, Vreeman GW, Meredith TC, Herzberg MC. | mSphere | 10.1128/msphere.00814-19 | 2019 | |
| The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential. | Milia E, Usai M, Szotakova B, Elstnerova M, Kralova V, D'hallewin G, Spissu Y, Barberis A, Marchetti M, Bortone A, Campanella V, Mastandrea G, Langhansova L, Eick S. | Antibiotics (Basel) | 10.3390/antibiotics9060281 | 2020 | | |
| Metabolism | Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts. | Gasiorek A, Dobosz E, Potempa B, Ciaston I, Wilamowski M, Oruba Z, Lamont RJ, Jura J, Potempa J, Koziel J. | mBio | 10.1128/mbio.00502-21 | 2021 | |
| Ursolic acid: biological functions and application in animal husbandry. | Liu G, Qin P, Cheng X, Wu L, Wang R, Gao W. | Front Vet Sci | 10.3389/fvets.2023.1251248 | 2023 | | |
| Metabolism | Metabolomic Studies of Oral Biofilm, Oral Cancer, and Beyond. | Washio J, Takahashi N. | Int J Mol Sci | 10.3390/ijms17060870 | 2016 | |
| Metabolism | The Oral Bacterium Fusobacterium nucleatum Binds Staphylococcus aureus and Alters Expression of the Staphylococcal Accessory Regulator sarA. | Lima BP, Hu LI, Vreeman GW, Weibel DB, Lux R. | Microb Ecol | 10.1007/s00248-018-1291-0 | 2019 | |
| Brazilian Red Propolis Is as Effective as Amoxicillin in Controlling Red-Complex of Multispecies Subgingival Mature Biofilm In Vitro. | de Figueiredo KA, da Silva HDP, Miranda SLF, Goncalves FJDS, de Sousa AP, de Figueiredo LC, Feres M, Bueno-Silva B. | Antibiotics (Basel) | 10.3390/antibiotics9080432 | 2020 | | |
| Metabolic activity of hydro-carbon-oxo-borate on a multispecies subgingival periodontal biofilm: a short communication. | Shibli JA, Rocha TF, Coelho F, de Oliveira Capote TS, Saska S, Melo MA, Pingueiro JMS, de Faveri M, Bueno-Silva B. | Clin Oral Investig | 10.1007/s00784-021-03900-0 | 2021 | | |
| Pellicle Modification with Casein and Mucin Does Not Promote In Vitro Bacterial Biofilm Formation. | Carvalho TS, Halter JE, Mucolli D, Lussi A, Eick S, Baumann T. | Oral Health Prev Dent | 10.3290/j.ohpd.a43351 | 2020 | | |
| Antimicrobial Efficiency of Pistacia lentiscus L. Derivates against Oral Biofilm-Associated Diseases-A Narrative Review. | Milia EP, Sardellitti L, Eick S. | Microorganisms | 10.3390/microorganisms11061378 | 2023 | | |
| Differential oxidative stress tolerance of Streptococcus mutans isolates affects competition in an ecological mixed-species biofilm model. | Liu Y, Palmer SR, Chang H, Combs AN, Burne RA, Koo H. | Environ Microbiol Rep | 10.1111/1758-2229.12600 | 2018 | | |
| Effect of a novel quaternary ammonium methacrylate polymer (QAMP) on adhesion and antibacterial properties of dental adhesives. | Pupo YM, Farago PV, Nadal JM, Simao LC, Esmerino LA, Gomes OM, Gomes JC. | Int J Mol Sci | 10.3390/ijms15058998 | 2014 | | |
| Pulsed Laser Photo-Crosslinking of Gelatin Methacryloyl Hydrogels for the Controlled Delivery of Chlorpromazine to Combat Antimicrobial Resistance. | Tozar T, Nistorescu S, Boni M, Gradisteanu Pircalabioru G, Negut I, Staicu A. | Pharmaceutics | 10.3390/pharmaceutics14102121 | 2022 | | |
| [Effects of Yili dark bee propolis on oral cariogenic biofilm in vitro]. | Yu Q, Lin J, Zulkarjan-Ahmat, Zhao J. | Hua Xi Kou Qiang Yi Xue Za Zhi | 10.7518/hxkq.2015.04.004 | 2015 | | |
| Enzymology | Evidence for recombination between a sialidase (nanH) of Actinomyces naeslundii and Actinomyces oris, previously named 'Actinomyces naeslundii genospecies 1 and 2'. | Do T, Henssge U, Gilbert SC, Clark D, Beighton D. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2008.01336.x | 2008 | |
| Metabolism | Acid tolerance in early colonizers of oral biofilms. | Boisen G, Davies JR, Neilands J. | BMC Microbiol | 10.1186/s12866-021-02089-2 | 2021 | |
| In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy. | Schmid JL, Kirchberg M, Sarembe S, Kiesow A, Sculean A, Mader K, Buchholz M, Eick S. | Pharmaceutics | 10.3390/pharmaceutics12040352 | 2020 | | |
| Pathogenicity | Effect of Antimicrobial Denture Base Resin on Multi-Species Biofilm Formation. | Zhang K, Ren B, Zhou X, Xu HH, Chen Y, Han Q, Li B, Weir MD, Li M, Feng M, Cheng L. | Int J Mol Sci | 10.3390/ijms17071033 | 2016 | |
| Pathogenicity | The inhibitory effect of quaternary ammonium salt on bacteria in root canal. | Kumar Tiwari S, Guo X, Huang Y, Zhou X, Xu HHK, Ren B, Peng X, Weir MD, Li M, Cheng L. | Sci Rep | 10.1038/s41598-019-48666-4 | 2019 | |
| Extracellular DNA and lipoteichoic acids interact with exopolysaccharides in the extracellular matrix of Streptococcus mutans biofilms. | Castillo Pedraza MC, Novais TF, Faustoferri RC, Quivey RG, Terekhov A, Hamaker BR, Klein MI. | Biofouling | 10.1080/08927014.2017.1361412 | 2017 | | |
| Trans,trans-farnesol, an antimicrobial natural compound, improves glass ionomer cement properties. | de Castilho ARF, Rosalen PL, de Souza Araujo IJ, Kitagawa IL, Costa CAGA, Janal MN, Alves MC, Duarte S, Lisboa Filho PN, Stipp RN, Puppin-Rontani RM. | PLoS One | 10.1371/journal.pone.0220718 | 2019 | | |
| Modeling of diffusion transport through oral biofilms with the inverse problem method. | Ma R, Liu J, Jiang YT, Liu Z, Tang ZS, Ye DX, Zeng J, Huang ZW. | Int J Oral Sci | 10.4248/ijos10075 | 2010 | | |
| Metabolism | Exopolysaccharides produced by Streptococcus mutans glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms. | Koo H, Xiao J, Klein MI, Jeon JG. | J Bacteriol | 10.1128/jb.01649-09 | 2010 | |
| Estimation of bacterial hydrogen sulfide production in vitro. | Basic A, Blomqvist S, Carlen A, Dahlen G. | J Oral Microbiol | 10.3402/jom.v7.28166 | 2015 | | |
| Phylogeny | Sequence analyses of fimbriae subunit FimA proteins on Actinomyces naeslundii genospecies 1 and 2 and Actinomyces odontolyticus with variant carbohydrate binding specificities. | Drobni M, Hallberg K, Ohman U, Birve A, Persson K, Johansson I, Stromberg N. | BMC Microbiol | 10.1186/1471-2180-6-43 | 2006 | |
| Induction of antibody response in the oral cavity of dogs following intraocular (eye drop) immunization with Porphyromonas gingivalis cell lysate incorporated in pH-sensitive fusogenic polymer-modified liposomes. | Shimizu Y, Iwasaki T, Tajima T, Yuba E, Kono K, Watarai S. | J Vet Med Sci | 10.1292/jvms.16-0338 | 2017 | | |
| Metabolism | l-Arginine Modifies the Exopolysaccharide Matrix and Thwarts Streptococcus mutans Outgrowth within Mixed-Species Oral Biofilms. | He J, Hwang G, Liu Y, Gao L, Kilpatrick-Liverman L, Santarpia P, Zhou X, Koo H. | J Bacteriol | 10.1128/jb.00021-16 | 2016 | |
| Pathogenicity | Effect of smokeless tobacco products on human oral bacteria growth and viability. | Liu M, Jin J, Pan H, Feng J, Cerniglia CE, Yang M, Chen H. | Anaerobe | 10.1016/j.anaerobe.2016.10.006 | 2016 | |
| Pathogenicity | In-vitro antibiofilm activity of chlorhexidine digluconate on polylactide-based and collagen-based membranes. | Rudolf JL, Moser C, Sculean A, Eick S. | BMC Oral Health | 10.1186/s12903-019-0979-y | 2019 | |
| Phylogeny | Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. | Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, Li X, Saxena D. | BMC Microbiol | 10.1186/1471-2180-12-144 | 2012 | |
| Enzymology | Phosphorylating enzymes involved in glucose fermentation of Actinomyces naeslundii. | Takahashi N, Kalfas S, Yamada T. | J Bacteriol | 10.1128/jb.177.20.5806-5811.1995 | 1995 | |
| Injectable MMP-Responsive Nanotube-Modified Gelatin Hydrogel for Dental Infection Ablation. | Ribeiro JS, Bordini EAF, Ferreira JA, Mei L, Dubey N, Fenno JC, Piva E, Lund RG, Schwendeman A, Bottino MC. | ACS Appl Mater Interfaces | 10.1021/acsami.9b22964 | 2020 | | |
| Metabolism | Cariogenic actinomyces identified with a beta-glucosidase-dependent green color reaction to Gardenia jasminoides extract. | Chen L, Ma L, Park NH, Shi W. | J Clin Microbiol | 10.1128/jcm.39.8.3009-3012.2001 | 2001 | |
| Metabolism | Streptococcus mutans protein synthesis during mixed-species biofilm development by high-throughput quantitative proteomics. | Klein MI, Xiao J, Lu B, Delahunty CM, Yates JR, Koo H. | PLoS One | 10.1371/journal.pone.0045795 | 2012 | |
| An ORMOSIL-containing orthodontic acrylic resin with concomitant improvements in antimicrobial and fracture toughness properties. | Gong SQ, Epasinghe J, Rueggeberg FA, Niu LN, Mettenberg D, Yiu CK, Blizzard JD, Wu CD, Mao J, Drisko CL, Pashley DH, Tay FR. | PLoS One | 10.1371/journal.pone.0042355 | 2012 | | |
| Pathogenicity | Effect of an oxygenating agent on oral bacteria in vitro and on dental plaque composition in healthy young adults. | Fernandez y Mostajo M, van der Reijden WA, Buijs MJ, Beertsen W, Van der Weijden F, Crielaard W, Zaura E. | Front Cell Infect Microbiol | 10.3389/fcimb.2014.00095 | 2014 | |
| Metabolism | Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape. | Aliko A, Kaminska M, Bergum B, Gawron K, Benedyk M, Lamont RJ, Malicki S, Delaleu N, Potempa J, Mydel P. | Sci Rep | 10.1038/s41598-018-32603-y | 2018 | |
| Study of humoral immunity to commensal oral bacteria in human infants demonstrates the presence of secretory immunoglobulin A antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 ribotypes. | Cole MF, Evans MK, Kirchherr JL, Sheridan MJ, Bowden GH. | Clin Diagn Lab Immunol | 10.1128/cdli.11.3.473-482.2004 | 2004 | | |
| Pathogenicity | Influences of trans-trans farnesol, a membrane-targeting sesquiterpenoid, on Streptococcus mutans physiology and survival within mixed-species oral biofilms. | Jeon JG, Pandit S, Xiao J, Gregoire S, Falsetta ML, Klein MI, Koo H. | Int J Oral Sci | 10.4248/ijos11038 | 2011 | |
| Subgingival microbiota in adult Down syndrome periodontitis. | Khocht A, Yaskell T, Janal M, Turner BF, Rams TE, Haffajee AD, Socransky SS. | J Periodontal Res | 10.1111/j.1600-0765.2011.01459.x | 2012 | | |
| Combined Application of Bacterial Predation and Violacein to Kill Polymicrobial Pathogenic Communities. | Im H, Choi SY, Son S, Mitchell RJ. | Sci Rep | 10.1038/s41598-017-14567-7 | 2017 | | |
| In Vitro-Activity of Er:YAG Laser in Comparison with other Treatment Modalities on Biofilm Ablation from Implant and Tooth Surfaces. | Eick S, Meier I, Spoerle F, Bender P, Aoki A, Izumi Y, Salvi GE, Sculean A. | PLoS One | 10.1371/journal.pone.0171086 | 2017 | | |
| Metabolism | The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. | Kaplan CW, Lux R, Haake SK, Shi W. | Mol Microbiol | 10.1111/j.1365-2958.2008.06503.x | 2009 | |
| Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells. | Edwards AM, Grossman TJ, Rudney JD. | Infect Immun | 10.1128/iai.74.1.654-662.2006 | 2006 | | |
| Enzymology | Development of species-specific primers for detection of Streptococcus mutans in mixed bacterial samples. | Chen Z, Saxena D, Caufield PW, Ge Y, Wang M, Li Y. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2007.00756.x | 2007 | |
| Leaves and Fruits Preparations of Pistacia lentiscus L.: A Review on the Ethnopharmacological Uses and Implications in Inflammation and Infection. | Milia E, Bullitta SM, Mastandrea G, Szotakova B, Schoubben A, Langhansova L, Quartu M, Bortone A, Eick S. | Antibiotics (Basel) | 10.3390/antibiotics10040425 | 2021 | | |
| Antibiotic effects on bacterial profile in osteonecrosis of the jaw. | Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D. | Oral Dis | 10.1111/j.1601-0825.2011.01848.x | 2012 | | |
| Humoral immunity to commensal oral bacteria in human infants: salivary antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 during colonization. | Cole MF, Bryan S, Evans MK, Pearce CL, Sheridan MJ, Sura PA, Wientzen R, Bowden GH. | Infect Immun | 10.1128/iai.66.9.4283-4289.1998 | 1998 | | |
| Metabolism | The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. | Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR, Heydorn A, Koo H. | PLoS Pathog | 10.1371/journal.ppat.1002623 | 2012 | |
| Metabolism | Different type 1 fimbrial genes and tropisms of commensal and potentially pathogenic Actinomyces spp. with different salivary acidic proline-rich protein and statherin ligand specificities. | Li T, Khah MK, Slavnic S, Johansson I, Stromberg N. | Infect Immun | 10.1128/iai.69.12.7224-7233.2001 | 2001 | |
| Pathogenicity | Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora. | Blount KF, Megyola C, Plummer M, Osterman D, O'Connell T, Aristoff P, Quinn C, Chrusciel RA, Poel TJ, Schostarez HJ, Stewart CA, Walker DP, Wuts PG, Breaker RR. | Antimicrob Agents Chemother | 10.1128/aac.01282-15 | 2015 | |
| Pathogenicity | Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology. | Guo L, McLean JS, Yang Y, Eckert R, Kaplan CW, Kyme P, Sheikh O, Varnum B, Lux R, Shi W, He X. | Proc Natl Acad Sci U S A | 10.1073/pnas.1506207112 | 2015 | |
| Microbial Biofilm Decontamination on Dental Implant Surfaces: A Mini Review. | Dhaliwal JS, Abd Rahman NA, Ming LC, Dhaliwal SKS, Knights J, Albuquerque Junior RF. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.736186 | 2021 | | |
| Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. | Soares GM, Teles F, Starr JR, Feres M, Patel M, Martin L, Teles R. | Antimicrob Agents Chemother | 10.1128/aac.04974-14 | 2015 | | |
| Enzymology | Identification of Streptococcus sanguinis with a PCR-generated species-specific DNA probe. | Li Y, Pan Y, Qi F, Caufield PW. | J Clin Microbiol | 10.1128/jcm.41.8.3481-3486.2003 | 2003 | |
| Enzymology | Genetic profiling of the oral microbiota associated with severe early-childhood caries. | Li Y, Ge Y, Saxena D, Caufield PW. | J Clin Microbiol | 10.1128/jcm.01622-06 | 2007 | |
| A Biofilm Pocket Model to Evaluate Different Non-Surgical Periodontal Treatment Modalities in Terms of Biofilm Removal and Reformation, Surface Alterations and Attachment of Periodontal Ligament Fibroblasts. | Hagi TT, Klemensberger S, Bereiter R, Nietzsche S, Cosgarea R, Flury S, Lussi A, Sculean A, Eick S. | PLoS One | 10.1371/journal.pone.0131056 | 2015 | | |
| Metabolism | Salivary receptors for GalNAc beta-sensitive adherence of Actinomyces spp.: evidence for heterogeneous GalNAc beta and proline-rich protein receptor properties. | Stromberg N, Boren T, Carlen A, Olsson J. | Infect Immun | 10.1128/iai.60.8.3278-3286.1992 | 1992 | |
| Metabolism | Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells. | Liu Y, Kamesh AC, Xiao Y, Sun V, Hayes M, Daniell H, Koo H. | Biomaterials | 10.1016/j.biomaterials.2016.07.042 | 2016 | |
| Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. | Marchesi JR, Sato T, Weightman AJ, Martin TA, Fry JC, Hiom SJ, Dymock D, Wade WG. | Appl Environ Microbiol | 10.1128/aem.64.2.795-799.1998 | 1998 | | |
| Enzymology | Multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. | Tran SD, Rudney JD. | J Clin Microbiol | 10.1128/jcm.34.11.2674-2678.1996 | 1996 | |
| Anti-Planktonic and Anti-Biofilm Properties of Pentacyclic Triterpenes-Asiatic Acid and Ursolic Acid as Promising Antibacterial Future Pharmaceuticals. | Sycz Z, Tichaczek-Goska D, Wojnicz D. | Biomolecules | 10.3390/biom12010098 | 2022 | | |
| Actinomyces viscosus fibril antigens detected by immunogold electron microscopy. | Ellen RP, Buivids IA, Simardone JR. | Infect Immun | 10.1128/iai.57.4.1327-1331.1989 | 1989 | | |
| Bacteroides gingivalis vesicles bind to and aggregate Actinomyces viscosus. | Ellen RP, Grove DA. | Infect Immun | 10.1128/iai.57.5.1618-1620.1989 | 1989 | | |
| Metabolism | Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. | Palmer RJ, Gordon SM, Cisar JO, Kolenbrander PE. | J Bacteriol | 10.1128/jb.185.11.3400-3409.2003 | 2003 | |
| Enzymology | Prevalence of viridans streptococci exhibiting lactose-inhibitable coaggregation with oral actinomycetes. | Kolenbrander PE, Williams BL. | Infect Immun | 10.1128/iai.41.2.449-452.1983 | 1983 | |
| Phylogeny | Assignment of Actinomyces viscosus and Actinomyces naeslundii strains to numerical taxonomy clusters by immunofluorescence based on antifibril antisera. | Ellen RP, Grove DA. | J Clin Microbiol | 10.1128/jcm.21.5.850-853.1985 | 1985 | |
| Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. | Loimaranta V, Jakubovics NS, Hytonen J, Finne J, Jenkinson HF, Stromberg N. | Infect Immun | 10.1128/iai.73.4.2245-2252.2005 | 2005 | | |
| Enzymology | Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. | Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. | Appl Environ Microbiol | 10.1128/aem.66.5.2263-2266.2000 | 2000 | |
| Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. | Tran SD, Rudney JD. | J Clin Microbiol | 10.1128/jcm.37.11.3504-3508.1999 | 1999 | | |
| Molecular approaches for viable bacterial population and transcriptional analyses in a rodent model of dental caries. | Klein MI, Scott-Anne KM, Gregoire S, Rosalen PL, Koo H. | Mol Oral Microbiol | 10.1111/j.2041-1014.2012.00647.x | 2012 | | |
| Salivary statherin peptide-binding epitopes of commensal and potentially infectious Actinomyces spp. delineated by a hybrid peptide construct. | Niemi LD, Johansson I. | Infect Immun | 10.1128/iai.72.2.782-787.2004 | 2004 | | |
| Metabolism | Actinomyces tissue specificity may depend on differences in receptor specificity for GalNAc beta-containing glycoconjugates. | Stromberg N, Boren T. | Infect Immun | 10.1128/iai.60.8.3268-3277.1992 | 1992 | |
| Immune labeling of certain strains of Actinomyces naeslundii and Actinomyces viscosus by fluorescence and electron microscopy. | Lai CH, Listgarten MA. | Infect Immun | 10.1128/iai.25.3.1016-1028.1979 | 1979 | | |
| Enzymology | A novel approach for detecting an immunodominant antigen of Porphyromonas gingivalis in diagnosis of adult periodontitis. | Kawai T, Ito HO, Sakato N, Okada H. | Clin Diagn Lab Immunol | 10.1128/cdli.5.1.11-17.1998 | 1998 | |
| Enzymology | Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis. | Kaman WE, Galassi F, de Soet JJ, Bizzarro S, Loos BG, Veerman EC, van Belkum A, Hays JP, Bikker FJ. | J Clin Microbiol | 10.1128/jcm.05313-11 | 2012 | |
| Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis. | Kolenbrander PE, Williams BL. | Infect Immun | 10.1128/iai.33.1.95-102.1981 | 1981 | | |
| Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp. | Yeung MK. | Infect Immun | 10.1128/iai.60.3.1047-1054.1992 | 1992 | | |
| Pathogenicity | In vitro evaluation of three iodine-containing compounds as antiplaque agents. | Tanzer JM, Slee AM, Kamay B, Scheer ER. | Antimicrob Agents Chemother | 10.1128/aac.12.1.107 | 1977 | |
| Metabolism | A 160-kilodalton epithelial cell surface glycoprotein recognized by plant lectins that inhibit the adherence of Actinomyces naeslundii. | Brennan MJ, Cisar JO, Sandberg AL. | Infect Immun | 10.1128/iai.52.3.840-845.1986 | 1986 | |
| Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. | Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjonneland A, Dahm CC, Overvad K, Jenab M, Fedirko V, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R, Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD, Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E, Dorronsoro M, Quiros JR, Duell EJ, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Bueno-de-Mesquita HB, Riboli E. | Gut | 10.1136/gutjnl-2012-303006 | 2013 | | |
| Enzymology | Isolation of Actinomyces bacteriophage from human dental plaque. | Tylenda CA, Calvert C, Kolenbrander PE, Tylenda A. | Infect Immun | 10.1128/iai.49.1.1-6.1985 | 1985 | |
| Enzymology | New Actinomyces and Streptococcus coaggregation groups among human oral isolates from the same site. | Kolenbrander PE, Inouye Y, Holdeman LV. | Infect Immun | 10.1128/iai.41.2.501-506.1983 | 1983 | |
| Factors affecting the aggregation of Actinomyces naeslundii during growth and in washed cell suspensions. | Miller CH, Palenik CJ, Stamper KE. | Infect Immun | 10.1128/iai.21.3.1003-1009.1978 | 1978 | | |
| In vitro activity of A-16686, a potential antiplaque agent. | Pallanza R, Scotti R, Beretta G, Cavalleri B, Arioli V. | Antimicrob Agents Chemother | 10.1128/aac.26.4.462 | 1984 | | |
| Presence of squalene in gram-positive bacteria. | Amdur BH, Szabo EI, Socransky SS. | J Bacteriol | 10.1128/jb.135.1.161-163.1978 | 1978 | | |
| Enzymology | Actinomyces naeslundii as an agent of human actinomycosis. | Coleman RM, Georg LK, Rozzell AR. | Appl Microbiol | 10.1128/am.18.3.420-426.1969 | 1969 | |
| Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria. | Okuda K, Kato T. | Infect Immun | 10.1128/iai.55.12.3192-3196.1987 | 1987 | | |
| Mannose-contaminating agglutinin for Actinomyces viscosus and Actinomyces naeslundii. | Ellen RP, Leung WL, Fillery ED, Grove DA. | Infect Immun | 10.1128/iai.26.2.427-434.1979 | 1979 | | |
| Relative hydrophobicities of Actinomyces viscosus and Actinomyces naeslundii strains and their adsorption to saliva-treated hydroxyapatite. | Clark WB, Lane MD, Beem JE, Bragg SL, Wheeler TT. | Infect Immun | 10.1128/iai.47.3.730-736.1985 | 1985 | | |
| Pathogenicity | In vitro evaluation of seven cationic detergents as antiplaque agents. | Tanzer JM, Slee AM, Kamay B, Scheer ER. | Antimicrob Agents Chemother | 10.1128/aac.15.3.408 | 1979 | |
| Enzymology | Detection of sialidase (neuraminidase) activity in Actinomyces species by using 2'-(4-methylumbelliferyl)alpha-D-N-acetylneuraminic acid in a filter paper spot test. | Moncla BJ, Braham P. | J Clin Microbiol | 10.1128/jcm.27.1.182-184.1989 | 1989 | |
| Phylogeny | Evaluation of the RapID ANA II and API ZYM systems for identification of Actinomyces species from clinical specimens. | Brander MA, Jousimies-Somer HR. | J Clin Microbiol | 10.1128/jcm.30.12.3112-3116.1992 | 1992 | |
| Comparative pathogenicity of Actinomyces naeslundii and Actinomyces israelii. | Coleman RM, Georg LK. | Appl Microbiol | 10.1128/am.18.3.427-432.1969 | 1969 | | |
| Pathogenicity | Antimicrobial activity of N,N'-dialkylpolymethylenediamines against some dental plaque bacteria. | Murata Y, Mita K, Miyamoto E, Ueda M. | Antimicrob Agents Chemother | 10.1128/aac.33.9.1636 | 1989 | |
| Multigeneric aggregations among oral bacteria: a network of independent cell-to-cell interactions. | Kolenbrander PE, Andersen RN. | J Bacteriol | 10.1128/jb.168.2.851-859.1986 | 1986 | | |
| Enzymology | Demonstration of Actinomyces and Arachnia species in cervicovaginal smears by direct staining with species-specific fluorescent-antibody conjugate. | Pine L, Malcolm GB, Curtis EM, Brown JM. | J Clin Microbiol | 10.1128/jcm.13.1.15-21.1981 | 1981 | |
| Pathogenicity | Bactericidal effects of a fusion protein of llama heavy-chain antibodies coupled to glucose oxidase on oral bacteria. | Szynol A, de Soet JJ, Sieben-van Tuyl E, Bos JW, Frenken LG. | Antimicrob Agents Chemother | 10.1128/aac.48.9.3390-3395.2004 | 2004 | |
| Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine. | Bruni N, Capucchio MT, Biasibetti E, Pessione E, Cirrincione S, Giraudo L, Corona A, Dosio F. | Molecules | 10.3390/molecules21060752 | 2016 | | |
| Enzymology | PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. | Wang RF, Cao WW, Cerniglia CE. | Appl Environ Microbiol | 10.1128/aem.62.4.1242-1247.1996 | 1996 | |
| Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. | Cisar JO, Kolenbrander PE, McIntire FC. | Infect Immun | 10.1128/iai.24.3.742-752.1979 | 1979 | | |
| Interference of secretory immunoglobulin A with sorption of oral bacteria to hydroxyapatite. | Kilian M, Roland K, Mestecky J. | Infect Immun | 10.1128/iai.31.3.942-951.1981 | 1981 | | |
| Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects. | Patters MR, Genco RJ, Reed MJ, Mashimo PA. | Infect Immun | 10.1128/iai.14.5.1213-1220.1976 | 1976 | | |
| Neuraminidase-dependent hamagglutination of human erythrocytes by human strains of Actinomyces viscosus and Actinomyces naeslundii. | Costello AH, Cisar JO, Kolenbrander PE, Gabriel O. | Infect Immun | 10.1128/iai.26.2.563-572.1979 | 1979 | | |
| Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs. | Takada H, Tsujimoto M, Kotani S, Kusumoto S, Inage M, Shiba T, Nagao S, Yano I, Kawata S, Yokogawa K. | Infect Immun | 10.1128/iai.25.2.645-652.1979 | 1979 | | |
| Metabolism | Sanguicin, a bacteriocin of oral Streptococcus sanguis. | Fujimura S, Nakamura T. | Antimicrob Agents Chemother | 10.1128/aac.16.3.262 | 1979 | |
| Enzymology | Comparison of randomly cloned and whole genomic DNA probes for the detection of Porphyromonas gingivalis and Bacteroides forsythus. | Wong M, DiRienzo JM, Lai CH, Listgarten MA. | J Periodontal Res | 10.1111/j.1600-0765.1996.tb00460.x | 1996 | |
| Inactivation of the gene encoding surface protein SspA in Streptococcus gordonii DL1 affects cell interactions with human salivary agglutinin and oral actinomyces. | Jenkinson HF, Terry SD, McNab R, Tannock GW. | Infect Immun | 10.1128/iai.61.8.3199-3208.1993 | 1993 | | |
| Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques. | Lambert FW, Brown JM, Georg LK. | J Bacteriol | 10.1128/jb.94.5.1287-1295.1967 | 1967 | | |
| Metabolism | Pseudomonas aeruginosa exoenzyme S is an adhesion. | Baker NR, Minor V, Deal C, Shahrabadi MS, Simpson DA, Woods DE. | Infect Immun | 10.1128/iai.59.9.2859-2863.1991 | 1991 | |
| Enzymology | Identification of Actinomyces, Arachnia, Bacterionema, Rothia, and Propionibacterium species by defined immunofluorescence. | Holmberg K, Forsum U. | Appl Microbiol | 10.1128/am.25.5.834-843.1973 | 1973 | |
| Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity. | Tanzer JM, Slee AM, Kamay BA. | Antimicrob Agents Chemother | 10.1128/aac.12.6.721 | 1977 | | |
| Enzymology | Quantitative microbiological study of human carious dentine by culture and real-time PCR: association of anaerobes with histopathological changes in chronic pulpitis. | Martin FE, Nadkarni MA, Jacques NA, Hunter N. | J Clin Microbiol | 10.1128/jcm.40.5.1698-1704.2002 | 2002 | |
| Phylogeny | Rapid identification of Actinomycetaceae and related bacteria. | Kilian M. | J Clin Microbiol | 10.1128/jcm.8.2.127-133.1978 | 1978 | |
| Enzymology | A bacteriocin of Actinobacillus actinomycetemcomitans. | Hammond BF, Lillard SE, Stevens RH. | Infect Immun | 10.1128/iai.55.3.686-691.1987 | 1987 | |
| Phylogeny | Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications. | Holmberg K, Nord CE, Wadstrom T. | Infect Immun | 10.1128/iai.12.2.398-403.1975 | 1975 | |
| Metabolism | Production, purification, and properties of a bacteriocin from Staphylococcus aureus isolated from saliva. | Nakamura T, Yamazaki N, Taniguchi H, Fujimura S. | Infect Immun | 10.1128/iai.39.2.609-614.1983 | 1983 | |
| Enzymology | Purification and properties of a bacteriocin-like substance (acnecin) of oral Propionibacterium acnes. | Fujimura S, Nakamura T. | Antimicrob Agents Chemother | 10.1128/aac.14.6.893 | 1978 | |
| Metabolism | Adsorption of lysozyme from human whole saliva by Streptococcus sanguis 903 and other oral microorganisms. | Laible NJ, Germaine GR. | Infect Immun | 10.1128/iai.36.1.148-159.1982 | 1982 | |
| Adherence of oral streptococci to salivary glycoproteins. | Murray PA, Prakobphol A, Lee T, Hoover CI, Fisher SJ. | Infect Immun | 10.1128/iai.60.1.31-38.1992 | 1992 | | |
| Enzymology | Isolation of gram-positive rods that resemble but are clearly distinct from Actinomyces pyogenes from mixed wound infections. | Wust J, Lucchini GM, Luthy-Hottenstein J, Brun F, Altwegg M. | J Clin Microbiol | 10.1128/jcm.31.5.1127-1135.1993 | 1993 | |
| Phylogeny | Predominant catalase-negative soil bacteria. I. Streptococcal population indigenous to soil. | Gledhill WE, Casida LE. | Appl Microbiol | 10.1128/am.17.2.208-213.1969 | 1969 | |
| Lymphoproliferative responses to oral bacteria in humans with varying severities of periodontal disease. | Patters MR, Chen P, McKenna J, Genco RJ. | Infect Immun | 10.1128/iai.28.3.777-784.1980 | 1980 | | |
| A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1. | Mizuno J, Cisar JO, Vatter AE, Fennessey PV, McIntire FC. | Infect Immun | 10.1128/iai.40.3.1204-1213.1983 | 1983 | | |
| Selective adsorption of heterophile polyglycerophosphate antigen from antigen extracts of Streptococcus mutans and other gram-positive bacteria. | Hamada S, Tai S, Slade HD. | Infect Immun | 10.1128/iai.14.4.903-910.1976 | 1976 | | |
| Morphological, biochemical, and serological studies on 64 strains of Actinomyces israelii. | Slack JM, Landfried S, Gerencser MA. | J Bacteriol | 10.1128/jb.97.2.873-884.1969 | 1969 | | |
| Racial Disparities in Plasma Cytokine and Microbiome Profiles. | Fan KD, Ogunrinde E, Wan Z, Li C, Jiang W. | Microorganisms | 10.3390/microorganisms12071453 | 2024 | | |
| The antimicrobial activity of theobromine against cariogenic microbes: an in vitro pilot study. | Rafiq IH, Dame-Teixeira N, Do T. | BDJ Open | 10.1038/s41405-024-00190-y | 2024 | | |
| Antimicrobial and Antibiofilm Activity of the Probiotic Strain Streptococcus salivarius K12 against Oral Potential Pathogens. | Staskova A, Sondorova M, Nemcova R, Kacirova J, Madar M. | Antibiotics (Basel) | 10.3390/antibiotics10070793 | 2021 | | |
| Phylogeny | Application of MLST and pilus gene sequence comparisons to investigate the population structures of Actinomyces naeslundii and Actinomyces oris. | Henssge U, Do T, Gilbert SC, Cox S, Clark D, Wickstrom C, Ligtenberg AJ, Radford DR, Beighton D. | PLoS One | 10.1371/journal.pone.0021430 | 2011 | |
| Phylogeny | Use of quantitative PCR and culture methods to characterize ecological flux in bacterial biofilms. | Dalwai F, Spratt DA, Pratten J. | J Clin Microbiol | 10.1128/jcm.01131-07 | 2007 | |
| Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. | Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR. | Appl Environ Microbiol | 10.1128/aem.02265-06 | 2007 | | |
| Modeling shifts in microbial populations associated with health or disease. | Dalwai F, Spratt DA, Pratten J. | Appl Environ Microbiol | 10.1128/aem.72.5.3678-3684.2006 | 2006 | | |
| Phylogeny | Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysis-mass spectrometry and conventional biochemical tests. | Hall V, O'Neill GL, Magee JT, Duerden BI. | J Clin Microbiol | 10.1128/jcm.37.7.2255-2261.1999 | 1999 | |
| Enzymology | Evaluation of a novel heminested PCR assay based on the phosphoglucosamine mutase gene for detection of Helicobacter pylori in saliva and dental plaque. | Goosen C, Theron J, Ntsala M, Maree FF, Olckers A, Botha SJ, Lastovica AJ, van der Merwe SW. | J Clin Microbiol | 10.1128/jcm.40.1.205-209.2002 | 2002 | |
| Targeting cariogenic pathogens and promoting competitiveness of commensal bacteria with a novel pH-responsive antimicrobial peptide. | Jiang W, Xie Z, Huang S, Huang Q, Chen L, Gao X, Lin Z. | J Oral Microbiol | 10.1080/20002297.2022.2159375 | 2023 | | |
| Metabolism | Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. | Imai K, Yamada K, Tamura M, Ochiai K, Okamoto T. | Cell Mol Life Sci | 10.1007/s00018-012-0936-2 | 2012 | |
| Metabolism | Denitrification by actinomycetes and purification of dissimilatory nitrite reductase and azurin from Streptomyces thioluteus. | Shoun H, Kano M, Baba I, Takaya N, Matsuo M. | J Bacteriol | 10.1128/jb.180.17.4413-4415.1998 | 1998 | |
| Phylogeny | Distribution and phylogenetic analysis of family 19 chitinases in Actinobacteria. | Kawase T, Saito A, Sato T, Kanai R, Fujii T, Nikaidou N, Miyashita K, Watanabe T. | Appl Environ Microbiol | 10.1128/aem.70.2.1135-1144.2004 | 2004 | |
| Metabolism | Role of urease enzymes in stability of a 10-species oral biofilm consortium cultivated in a constant-depth film fermenter. | Shu M, Browngardt CM, Chen YY, Burne RA. | Infect Immun | 10.1128/iai.71.12.7188-7192.2003 | 2003 | |
| Metabolism | Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyrene by caseinoglycopeptide derivatives. | Neeser JR, Chambaz A, Del Vedovo S, Prigent MJ, Guggenheim B. | Infect Immun | 10.1128/iai.56.12.3201-3208.1988 | 1988 | |
| Pathogenicity | Removal of Dental Biofilms with an Ultrasonically Activated Water Stream. | Howlin RP, Fabbri S, Offin DG, Symonds N, Kiang KS, Knee RJ, Yoganantham DC, Webb JS, Birkin PR, Leighton TG, Stoodley P | J Dent Res | 10.1177/0022034515589284 | 2015 | |
| Pathogenicity | Effect of water-aging on the antimicrobial activities of an ORMOSIL-containing orthodontic acrylic resin. | Gong SQ, Epasinghe DJ, Zhou B, Niu LN, Kimmerling KA, Rueggeberg FA, Yiu CK, Mao J, Pashley DH, Tay FR | Acta Biomater | 10.1016/j.actbio.2013.02.031 | 2013 | |
| Pathogenicity | Quaternary ammonium silane-functionalized, methacrylate resin composition with antimicrobial activities and self-repair potential. | Gong SQ, Niu LN, Kemp LK, Yiu CK, Ryou H, Qi YP, Blizzard JD, Nikonov S, Brackett MG, Messer RL, Wu CD, Mao J, Bryan Brister L, Rueggeberg FA, Arola DD, Pashley DH, Tay FR | Acta Biomater | 10.1016/j.actbio.2012.05.031 | 2012 | |
| Pathogenicity | Effect of saliva viscosity on the co-aggregation between oral streptococci and Actinomyces naeslundii. | Kitada K, Oho T | Gerodontology | 10.1111/j.1741-2358.2011.00595.x | 2011 | |
| [Initial study on the discrimination of oral common Actinomycetes with metabonomics method]. | Li MY, Guo Q, Zhou XD, Xiong P, Jia XM, Xiao XR, Li W, Xiao LY | Hua Xi Kou Qiang Yi Xue Za Zhi | 2009 | | ||
| Cultivation | Regulation of urease expression of Actinomyces naeslundii in biofilms in response to pH and carbohydrate. | Liy Y, Dan J, Tao H, Xuedong Z | Oral Microbiol Immunol | 10.1111/j.1399-302X.2008.00430.x | 2008 | |
| Pathogenicity | Impact of growth conditions on susceptibility of five microbial species to alkaline stress. | Brandle N, Zehnder M, Weiger R, Waltimo T | J Endod | 10.1016/j.joen.2008.02.027 | 2008 | |
| Metabolism | Regulation of urease gene of Actinomyces naeslundii in biofilms in response to environmental factors. | Liu Y, Hu T, Jiang D, Zhang J, Zhou X | FEMS Microbiol Lett | 10.1111/j.1574-6968.2007.00959.x | 2007 | |
| Enzymology | Characterization of the Actinomyces naeslundii ureolysis and its role in bacterial aciduricity and capacity to modulate pH homeostasis. | Liu Y, Hu T, Zhang J, Zhou X | Microbiol Res | 10.1016/j.micres.2005.11.002 | 2006 | |
| Enzymology | Production and characterization of species-specific monoclonal antibodies against Actinomyces naeslundii and Lactobacillus casei. | Gu F, Ma X, Lux R, Shi W | Hybrid Hybridomics | 10.1089/153685902321044007 | 2002 | |
| Metabolism | Roles of fructosyltransferase and levanase-sucrase of Actinomyces naeslundii in fructan and sucrose metabolism. | Bergeron LJ, Burne RA | Infect Immun | 10.1128/IAI.69.9.5395-5402.2001 | 2001 | |
| Enzymology | Analysis of urease expression in Actinomyces naeslundii WVU45. | Morou-Bermudez E, Burne RA | Infect Immun | 10.1128/IAI.68.12.6670-6676.2000 | 2000 | |
| Metabolism | Characterization of the fructosyltransferase gene of Actinomyces naeslundii WVU45. | Bergeron LJ, Morou-Bermudez E, Burne RA | J Bacteriol | 10.1128/JB.182.13.3649-3654.2000 | 2000 | |
| Pathogenicity | In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. | Koo H, Gomes BP, Rosalen PL, Ambrosano GM, Park YK, Cury JA | Arch Oral Biol | 10.1016/s0003-9969(99)00117-x | 2000 | |
| Metabolism | Secretory immunoglobulin A heavy chain presents Galbeta1-3GalNAc binding structures for Actinomyces naeslundii genospecies 1. | Bratt P, Boren, Boren T, Str omberg N | J Dent Res | 10.1177/00220345990780060701 | 1999 | |
| Pathogenicity | Genetic and physiologic characterization of urease of Actinomyces naeslundii. | Morou-Bermudez E, Burne RA | Infect Immun | 10.1128/IAI.67.2.504-512.1999 | 1999 | |
| Pathogenicity | Anaerobic killing of oral streptococci by reduced, transition metal cations. | Dunning JC, Ma Y, Marquis RE | Appl Environ Microbiol | 10.1128/AEM.64.1.27-33.1998 | 1998 | |
| Genetics | Synthesis and function of Actinomyces naeslundii T14V type 1 fimbriae require the expression of additional fimbria-associated genes. | Yeung MK, Ragsdale PA | Infect Immun | 10.1128/iai.65.7.2629-2639.1997 | 1997 | |
| Pathogenicity | Cell surface polypeptide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin. | McNab R, Holmes AR, Clarke JM, Tannock GW, Jenkinson HF | Infect Immun | 10.1128/iai.64.10.4204-4210.1996 | 1996 | |
| Phylogeny | Detection of Actinomyces species using nonradioactive riboprobes coupled with polymerase chain reaction. | Kiyama M, Hiratsuka K, Saito S, Shiroza T, Takiguchi H, Abiko Y | Biochem Mol Med | 10.1006/bmme.1996.0043 | 1996 | |
| Metabolism | Putative glycoprotein and glycolipid polymorphonuclear leukocyte receptors for the Actinomyces naeslundii WVU45 fimbrial lectin. | Sandberg AL, Ruhl S, Joralmon RA, Brennan MJ, Sutphin MJ, Cisar JO | Infect Immun | 10.1128/iai.63.7.2625-2631.1995 | 1995 | |
| Metabolism | Surface-associated properties of Actinomyces strains and their potential relation to pathogenesis. | Loo CY, Willcox MD, Knox KW | Oral Microbiol Immunol | 10.1111/j.1399-302x.1994.tb00208.x | 1994 | |
| Phylogeny | Characterization of Actinomyces with genomic DNA fingerprints and rRNA gene probes. | Bowden G, Johnson J, Schachtele C | J Dent Res | 10.1177/00220345930720080201 | 1993 | |
| Metabolism | Interactions of Actinomyces naeslundii strains T14V and ATCC 12104 with saliva, collagen and fibrinogen. | Hawkins BW, Cannon RD, Jenkinson HF | Arch Oral Biol | 10.1016/0003-9969(93)90191-n | 1993 | |
| Stress | Coaggregation of Prevotella intermedia with oral Actinomyces species. | Nesbitt WE, Fukushima H, Leung KP, Clark WB | Infect Immun | 10.1128/iai.61.5.2011-2014.1993 | 1993 | |
| Metabolism | Binding of Actinomyces viscosus to collagen: association with the type 1 fimbrial adhesin. | Liu T, Gibbons RJ, Hay DI, Skobe Z | Oral Microbiol Immunol | 10.1111/j.1399-302x.1991.tb00443.x | 1991 | |
| Metabolism | Characterization of the binding of Actinomyces naeslundii (ATCC 12104) and Actinomyces viscosus (ATCC 19246) to glycosphingolipids, using a solid-phase overlay approach. | Stromberg N, Karlsson KA | J Biol Chem | S0021-9258(19)38584-9 | 1990 | |
| Genetics | Sequence homology between the subunits of two immunologically and functionally distinct types of fimbriae of Actinomyces spp. | Yeung MK, Cisar JO | J Bacteriol | 10.1128/jb.172.5.2462-2468.1990 | 1990 | |
| Pathogenicity | Cellular coaggregation of oral Streptococcus milleri with actinomyces. | Eifuku H, Yakushiji T, Mizuno J, Kudo N, Inoue M | Infect Immun | 10.1128/iai.58.1.163-168.1990 | 1990 | |
| Enzymology | Cloning and nucleotide sequence of a gene for Actinomyces naeslundii WVU45 type 2 fimbriae. | Yeung MK, Cisar JO | J Bacteriol | 10.1128/jb.170.9.3803-3809.1988 | 1988 | |
| Metabolism | Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. | Gibbons RJ, Hay DI | Infect Immun | 10.1128/iai.56.2.439-445.1988 | 1988 | |
| Metabolism | Binding of Actinomyces naeslundii to glycosphingolipids. | Brennan MJ, Joralmon RA, Cisar JO, Sandberg AL | Infect Immun | 10.1128/iai.55.2.487-489.1987 | 1987 | |
| Pathogenicity | Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells. | Brennan MJ, Cisar JO, Vatter AE, Sandberg AL | Infect Immun | 10.1128/iai.46.2.459-464.1984 | 1984 | |
| Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii. | Cisar JO, David VA, Curl SH, Vatter AE | Infect Immun | 10.1128/iai.46.2.453-458.1984 | 1984 | | |
| Pathogenicity | Neuraminidase-activated attachment of Actinomyces naeslundii ATCC 12104 to human buccal epithelial cells. | Saunders JM, Miller CH | J Dent Res | 10.1177/00220345830620100501 | 1983 | |
| Pathogenicity | Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45. | McIntire FC, Crosby LK, Barlow JJ, Matta KL | Infect Immun | 10.1128/iai.41.2.848-850.1983 | 1983 | |
| Stress | Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis. | Kolenbrander PE | Infect Immun | 10.1128/iai.37.3.1200-1208.1982 | 1982 | |
| Enzymology | Novel antigens of oral Actinomyces species prepared from a cell wall enzyme lysate. | Hamada S, Okahashi N, Kimura S, Imanishi H, Koga T, Kawata S, Michalek SM, McGhee JR | Jpn J Med Sci Biol | 10.7883/yoken1952.35.171 | 1982 | |
| Pathogenicity | Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces. | Qureshi JV, Gibbons RJ | Infect Immun | 10.1128/iai.31.1.261-266.1981 | 1981 | |
| Pathogenicity | Attachment of Actinomyces naeslundii to human buccal epithelial cells. | Saunders JM, Miller CH | Infect Immun | 10.1128/iai.29.3.981-989.1980 | 1980 | |
| Metabolism | Degradation of sucrose by whole cells and plaque of Actinomyces naeslundii. | Miller CH | Infect Immun | 10.1128/iai.10.6.1280-1291.1974 | 1974 | |
| Genetics | Genome characterisation and comparative analysis of Schaalia dentiphila sp. nov. and its subspecies, S. dentiphila subsp. denticola subsp. nov., from the human oral cavity. | Tian X, Teo WFA, Yang Y, Dong L, Wong A, Chen L, Ahmed H, Choo SW, Jakubovics NS, Tan GYA. | BMC Microbiol | 10.1186/s12866-024-03346-w | 2024 | |
| 'Enterococcus timonensis' sp. nov., 'Actinomyces marseillensis' sp. nov., 'Leptotrichia massiliensis' sp. nov., 'Actinomyces pacaensis' sp. nov., 'Actinomyces oralis' sp. nov., 'Actinomyces culturomici' sp. nov. and 'Gemella massiliensis' sp. nov., new bacterial species isolated from the human respiratory microbiome. | Fonkou MDM, Bilen M, Cadoret F, Fournier PE, Dubourg G, Raoult D. | New Microbes New Infect | 10.1016/j.nmni.2017.12.005 | 2018 | | |
| Genetics | Noncontiguous finished genome sequences and descriptions of Actinomyces ihuae, Actinomyces bouchesdurhonensis, Actinomyces urinae, Actinomyces marseillensis, Actinomyces mediterranea and Actinomyces oralis sp. nov. identified by culturomics. | Mbogning Fonkou MD, Mailhe M, Ndongo S, Ricaboni D, Morand A, Cornu F, Tidjani Alou M, Bilen M, Andrieu C, Levasseur A, Cadoret F, Raoult D. | New Microbes New Infect | 10.1016/j.nmni.2018.06.004 | 2018 | |
| Phylogeny | Emended description of Actinomyces naeslundii and descriptions of Actinomyces oris sp. nov. and Actinomyces johnsonii sp. nov., previously identified as Actinomyces naeslundii genospecies 1, 2 and WVA 963. | Henssge U, Do T, Radford DR, Gilbert SC, Clark D, Beighton D | Int J Syst Evol Microbiol | 10.1099/ijs.0.000950-0 | 2009 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive154.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License